| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
9,168 |
7,845 |
$1.25M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,149 |
3,642 |
$69K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,036 |
2,772 |
$64K |
| 96127 |
|
811 |
687 |
$40K |
| 3074F |
|
770 |
705 |
$39K |
| 3078F |
|
685 |
619 |
$36K |
| 3079F |
|
428 |
406 |
$23K |
| 3077F |
|
300 |
286 |
$17K |
| 3075F |
|
266 |
248 |
$15K |
| 3080F |
|
207 |
195 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
188 |
166 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
116 |
116 |
$5K |
| 90658 |
|
90 |
90 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
158 |
127 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
115 |
98 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
236 |
204 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
217 |
186 |
$0.00 |
| 90656 |
|
28 |
28 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
108 |
94 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
32 |
21 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$0.00 |